Business Description

Agilon Health Inc
NAICS : 623312
SIC : 8099
Description
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.44 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.61 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 7.86 | |||||
Beneish M-Score | -1.77 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate | 46.79 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.88 | |||||
9-Day RSI | 73.19 | |||||
14-Day RSI | 68.96 | |||||
6-1 Month Momentum % | -35.52 | |||||
12-1 Month Momentum % | -2.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 2.48 | |||||
Cash Ratio | 1.46 | |||||
Days Sales Outstanding | 72.17 | |||||
Days Payable | 80.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 4.51 | |||||
Operating Margin % | -4 | |||||
Net Margin % | -4.3 | |||||
ROE % | -9.67 | |||||
ROA % | -6.04 | |||||
ROIC % | -40.53 | |||||
ROC (Joel Greenblatt) % | -266.88 | |||||
ROCE % | -8.36 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 146.53 | |||||
PS Ratio | 3.66 | |||||
PB Ratio | 8.33 | |||||
Price-to-Tangible-Book | 9.21 | |||||
EV-to-EBIT | -77.97 | |||||
EV-to-EBITDA | -89.69 | |||||
EV-to-Revenue | 3.25 | |||||
EV-to-Forward-Revenue | 2.09 | |||||
EV-to-FCF | -51.14 | |||||
Price-to-Net-Current-Asset-Value | 10.68 | |||||
Price-to-Net-Cash | 52.38 | |||||
Earnings Yield (Greenblatt) % | -1.28 |